South Korea Builds AI Health Tech, Now Fixing Sales Gap

South Korea has cracked the code on creating AI healthcare technology, but discovered a surprising problem along the way.

The country approved 45 innovative AI medical devices in 2025 and has 16 AI radiology tools already working in hospitals. That's real progress, not just research papers. But here's the twist: most of these validated technologies aren't turning into thriving companies or reaching patients at scale.

Dr. Wonju Hwangbo, CEO of AORAEL, puts it simply: "Many technologies remain validated but not adopted." It's not a failure of invention, it's a failure of conversion.

The problem sits in an invisible gap between "this works" and "hospitals are buying it." A device can prove it saves lives, pass all safety tests, and still struggle to reach patients. South Korea's government is now tackling this head-on.

The challenge isn't one big wall, it's a maze of disconnected systems. Getting regulatory approval from one agency doesn't guarantee payment approval from another. The process can take 460 days even with recent improvements, and pricing decisions happen separately from safety reviews.

South Korea introduced its first fast-track reimbursement in December 2023, opening access to 200,000 patients. The government has also launched new programs specifically targeting the commercialization stage, helping companies generate real-world evidence and navigate payment systems after their technology is already approved.

Why This Inspires

What makes this story hopeful isn't just the innovation, it's the honesty. South Korea built something impressive, noticed where it was breaking down, and adjusted course. Instead of celebrating approvals and moving on, policymakers asked why hospitals weren't actually buying what got approved.

The government's new focus on post-approval support, economic evaluation, and hospital partnerships shows a maturing ecosystem. They're building bridges between the labs that create AI tools and the hospitals that need them. Training programs are helping companies navigate payment systems, and data-sharing initiatives are making it easier to prove technologies work in real-world conditions.

This matters beyond South Korea's borders. Every country developing medical AI will face this same conversion problem. South Korea is building a playbook for turning validated technology into patient care at scale.

The next chapter isn't about inventing more AI, it's about getting existing innovations into the hands of doctors and patients who need them.